Among these 9 candidate targets, AGT, DRD2, IL-1B, and IL-6 were significantly increased in primary tumor compared with the normal tissues, while ALB, IL-10, and IGF1 were significantly decreased in COAD tissues. This evidence concerns the gene IL6 and colon adenocarcinoma.